Skip to main content
Clinical Trials/CTRI/2019/08/020579
CTRI/2019/08/020579
Recruiting
Phase 2

Clinical evaluation of the efficacy of ââ?¬Å?Ayush SS Granulesââ?¬? in exclusively breast feeding mothers with Insufficient Lactation (Stanyalpata)- A Randomized Double blind placebo control trial

ICMR0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
Sponsor
ICMR
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ICMR

Eligibility Criteria

Inclusion Criteria

  • 1 Exclusively breast feeding mothers with complaint of insufficient lactation.
  • 2 Age between 20\-40 years
  • 3 Full Term Delivery ââ?°Â¥ 37 weeks
  • 4 Primi or multipara with singleton baby
  • 5 Willing and able to give written consent
  • 6 Baby with birth weight ââ?°Â¥ 2\.5 kg who has not attained actual birth weight by 14 days
  • 7 After 14 days of age weight gain less than 20gm/day from 15th day of birth to 3rd month of birth
  • 8 Urination less than 6 times/day

Exclusion Criteria

  • 1 Mothers with active herpes breast/breast abscess/retracted nipple/severely cracked nipples, having HbsAg\+ve, HIV\+ve, Tuberculosis, Chronic medical conditions.
  • 2 Mother is taking medicine like Pseudoephedrine, methargin, bromocriptine, any other galactogogues (Allopathic/Ayurvedic)
  • 3 Mother having Malignancy and Diabetes melitus
  • 4 Neonate with congenital malformations which may interfere in breast feeding or requiring surgery in first six months of life.
  • 5 Baby with acute respiratory infection, pneumonia, urinary tract infection, infective diarrhoea, meningitis at the time of recruitment
  • Subjects will be enrolled in to the study after satisfying the inclusion/exclusion criteria. Each subject will be assigned a unique subject number, which identifies the individual.

Outcomes

Primary Outcomes

Not specified

Similar Trials